Wei Wei

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg, Kurt A. Schalper, Scott Gettinger et al. · The Lancet Oncology · 2020 · 523 citations · Full text

Neuro-oncology, Prognostic Biomarkers, Biomarker Analysis +11

Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial

Harriet M. Kluger, Veronica Chiang, Amit Mahajan et al. · Journal of Clinical Oncology · 2018 · 275 citations

Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma

Pok Fai Wong, Wei Wei, James W. Smithy et al. · Clinical Cancer Research · 2019 · 211 citations · Full text

Methods for Analysis of Pre-Post Data in Clinical Research: A Comparison of Five Common Methods

Nathaniel S. O’Connell, Lin Dai, Yunyun Jiang et al. · Journal of Biometrics & Biostatistics · 2017 · 181 citations · Full text

Clinical Specialties, Treatment Effect, Post Treatment Measurement +19

Role of the Indirect Pathway of the Basal Ganglia in Perceptual Decision Making

Wei Wei, Jonathan E. Rubin, Xiao‐Jing Wang · Journal of Neuroscience · 2015 · 100 citations · Full text